MariMed Q2 Sales $36.52M Beat $35.50M Estimate
Portfolio Pulse from vinayak@benzinga.com
MariMed reported Q2 sales of $36.52 million, beating the analyst consensus estimate of $35.50 million by 2.87 percent. This represents a 10.71 percent increase over sales of $32.99 million in the same period last year.
August 04, 2023 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MariMed's Q2 sales exceeded analyst estimates by 2.87%, indicating a strong financial performance.
MariMed's Q2 sales exceeded the analyst consensus, which is a positive signal for the company's financial performance. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100